Literature DB >> 15063030

Microwave-treated gelatin microspheres as drug delivery system.

Maria Angela Vandelli1, Marcello Romagnoli, Alessandra Monti, Manuela Gozzi, Paolo Guerra, Francesco Rivasi, Flavio Forni.   

Abstract

The crosslinking process of natural macromolecules with microwave energy should have the potentiality to overcome the problems due to the toxicity of the residuals of chemical crosslinking agents and moreover of the "in vivo" biodegradation products of the chemical crosslinked macromolecule. To evaluate the effective crosslinking of the gelatin forming the microspheres, the water-soluble fraction at 37 degrees C, the water absorption capability, the free amino and free carboxylic acid groups of the gelatin were determined. The structural change in the gelatin microspheres has been detected by the porosity studies. Moreover, both the "in vitro" biodegradability and the biocompatibility of the gelatin microspheres microwave-treated after a subcutaneous injection into female albino guinea pigs were tested. As the results suggest only the gelatin microspheres microwave-treated for 10 min at an inlet temperature of 250 degrees C could have been modified by the crosslink formation among the macromolecular chains. The gelatin microspheres treated with the microwave energy were very well biodegraded as indicated both by the "in vitro" enzymatic degradation studies and mainly by the histopathological examination. This latter study has also demonstrated the biocompatibility of the gelatin microspheres crosslinked with the microwave energy. In order to evaluate the feasibility of the microwave crosslinking process for pharmaceutical applications, both the drug loading and the drug release processes were evaluated using diclofenac as drug model, either as acidic form or as sodium salt. The microspheres were swollen in aqueous solution of diclofenac sodium salt, followed by a washing procedure with cool water to maintain the sodium salt into the microspheres or with pH 1.5 HCl to induce the diclofenac precipitation. To increase the amount of diclofenac acid form in the microspheres, the procedure was repeated three times washing with pH 1.5 HCl after each swelling process. Both the X-ray diffractometry and thermal analysis investigations showed a different physical state of the two drug forms in the microspheres, i.e. the amorphous state of the sodium salt and the crystalline state of the acidic form. According to the experimental results, the drug is released from gelatin microspheres according to the drug loading and the drug solubility.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063030     DOI: 10.1016/j.jconrel.2004.01.009

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  5 in total

1.  The effect of microwave thermal denaturation on release properties of bovine serum albumin and gluten matrices.

Authors:  Rani J Qasem
Journal:  AAPS PharmSciTech       Date:  2006-02-10       Impact factor: 3.246

2.  Genipin-crosslinked chitosan/gelatin blends for biomedical applications.

Authors:  Valeria Chiono; Ettore Pulieri; Giovanni Vozzi; Gianluca Ciardelli; Arti Ahluwalia; Paolo Giusti
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

3.  Feasibility of ablative fractional laser-assisted drug delivery with optical coherence tomography.

Authors:  Chih-Hsun Yang; Meng-Tsan Tsai; Su-Chin Shen; Chau Yee Ng; Shih-Ming Jung
Journal:  Biomed Opt Express       Date:  2014-10-16       Impact factor: 3.732

4.  Gelatin-stabilized composites of silver nanoparticles and curcumin: characterization, antibacterial and antioxidant study.

Authors:  Ly Loan Khanh; Nguyen Thanh Truc; Nguyen Tan Dat; Nguyen Thi Phuong Nghi; Vo van Toi; Nguyen Thi Thu Hoai; Tran Ngoc Quyen; Tran Thi Thanh Loan; Nguyen Thi Hiep
Journal:  Sci Technol Adv Mater       Date:  2019-03-29       Impact factor: 8.090

5.  Synthesis and Evaluation of BMMSC-seeded BMP-6/nHAG/GMS Scaffolds for Bone Regeneration.

Authors:  Xuewen Li; Ran Zhang; Xuexin Tan; Bo Li; Yao Liu; Xukai Wang
Journal:  Int J Med Sci       Date:  2019-06-10       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.